Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Trust & governance

Conflicts of Interest

Released: · Last reviewed:

How relationships are disclosed and managed.

This page states how publisher, author, reviewer, provider, pharmacy, affiliate, and financial relationships are handled. Any material relationship triggers disclosure and editorial recusal, and never earns a provider an easier evidence standard or a changed price figure.

Covered relationships

Ownership, employment, affiliate or referral compensation, advertising, shared staff or contractors, sponsored content, and data relationships across the publisher, authors, reviewers, providers, and pharmacies.

Current disclosed relationships

As of November 8, 2026: the site is affiliate-supported and may earn a commission when readers enroll through links, including NexLife links (see ownership and funding). No other covered provider or pharmacy relationship is on record.

Recusal

A person with a material relationship to a covered entity recuses from writing, reviewing, or ranking that entity. NexLife’s #1 placement is an editorial pick under the published v4.1 rubric and is disclosed as such.

Frequently asked questions

Does a relationship change a provider's ranking?

The relationship and the ranking rule are both disclosed: NexLife is the #1 overall editorial pick under the v4.1 rubric, and other programs are listed alphabetically pending re-score. Prices are reported as each program prints them.

Publisher: Microdose GLP One. Compounded medications are not FDA approved. Questions or corrections: see the corrections policy and contact page.